Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Otorhinolaryngology

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 71 articles: HTML format

Single Articles

February 2025
1. WANG H, Fan T, Lu Y, Que L, et al
   Baseline audiometric assessment of newly diagnosed nasopharyngeal carcinoma patients: a multicentre cross-sectional study.
   Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35358.
   PubMed     Abstract available
   
   
   January 2025
2. XIAO Z, Chen W, Du Y, Zeng F, et al
   Efficacy and safety of Anlotinib in combination with gemcitabine and cisplatin as a first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A single-arm clinical trial.
   Int J Cancer. 2025 Jan 18. doi: 10.1002/ijc.35340.
   PubMed     Abstract available
   
   
   December 2024
3. WANG J, Li B, Zhang Y, Luo X, et al
   Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial.
   Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35261.
   PubMed     Abstract available
   
   
   
4. JHAWAR SR, Haring C, Pan X, Ma J, et al
   Impact of circulating tumor human papillomavirus DNA kinetics on disease outcomes in HPV-associated oropharyngeal cancer.
   Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35291.
   PubMed     Abstract available
   
   
   November 2024
5. JIN ZY, Liu K, Wallar G, Zhou JY, et al
   Environmental tobacco smoking (ETS) and esophageal cancer: A population-based case-control study in Jiangsu Province, China.
   Int J Cancer. 2024 Nov 18. doi: 10.1002/ijc.35254.
   PubMed     Abstract available
   
   
   
6. ABUSAMAK M, Abu-Samak AA, Cai W, Al-Waeli H, et al
   Chronotherapy in head and neck cancer: A systematic review and meta-analysis.
   Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35234.
   PubMed     Abstract available
   
   
   
7. RUTKOWSKI TW, Kurczyk A, Drosik-Rutowicz K, Kiprian D, et al
   Nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Results of Polish multicenter observational study.
   Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35248.
   PubMed     Abstract available
   
   
   October 2024
8. 
   RETRACTION: A Multiplicity of Anti-Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer.
   Int J Cancer. 2024 Oct 22. doi: 10.1002/ijc.35230.
   PubMed     Abstract available
   
   
   
9. HSU WL, Tao J, Fu S, Yu KJ, et al
   Kinetics of EBV antibody-based NPC risk scores in Taiwan NPC multiplex families.
   Int J Cancer. 2024;155:1400-1408.
   PubMed     Abstract available
   
   
   September 2024
10. WANG W, Ye L, Li H, Chen W, et al
    A narrative review on advances in neoadjuvant immunotherapy for esophageal cancer: Molecular biomarkers and future directions.
    Int J Cancer. 2024 Sep 14. doi: 10.1002/ijc.35153.
    PubMed     Abstract available
    
    
    
11. PIRES C, Marques IJ, Saramago A, Moura MM, et al
    Identification of novel candidate predisposing genes in familial nonmedullary thyroid carcinoma implicating DNA damage repair pathways.
    Int J Cancer. 2024 Sep 9. doi: 10.1002/ijc.35159.
    PubMed     Abstract available
    
    
    August 2024
12. JANKE F, Stritzke F, Dvornikovich K, Franke H, et al
    Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
    Int J Cancer. 2024 Aug 30. doi: 10.1002/ijc.35152.
    PubMed     Abstract available
    
    
    
13. SHI X, Lu M, Li X, Li J, et al
    The transcriptional landscape and clinico-biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma.
    Int J Cancer. 2024 Aug 27. doi: 10.1002/ijc.35147.
    PubMed     Abstract available
    
    
    
14. HUANG H, Zhao Y, Deng Y, Zhan Z, et al
    Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.
    Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139.
    PubMed     Abstract available
    
    
    July 2024
15. WENG Z, Mai Z, Yuan J, Liu Q, et al
    Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy.
    Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35118.
    PubMed     Abstract available
    
    
    
16. LAURITZEN BB, Gronlund MW, Jakobsen KK, Justesen MM, et al
    Epidemiological trends and survival of oropharyngeal cancer in a high HPV-prevalent area: A Danish population-based study from 2000 to 2020.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35099.
    PubMed     Abstract available
    
    
    June 2024
17. MA L, Wang TM, He YQ, Liao Y, et al
    Multiplex assays reveal anti-EBV antibody profile and its implication in detection and diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2024 Jun 18. doi: 10.1002/ijc.35061.
    PubMed     Abstract available
    
    
    
18. SUN X, Lin X, Yao J, Tian T, et al
    Potential causal links of long-term exposure to PM(2.5) and its chemical components with the risk of nasopharyngeal carcinoma recurrence: A 10-year cohort study in South China.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35047.
    PubMed     Abstract available
    
    
    May 2024
19. GUO D, Jin J, Li D, He Y, et al
    Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35003.
    PubMed     Abstract available
    
    
    April 2024
20. VASILIADOU I, Grose D, Wilson C, Thapa A, et al
    The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34963.
    PubMed     Abstract available
    
    
    
21. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    PubMed     Abstract available
    
    
    
22. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    PubMed     Abstract available
    
    
    
23. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    PubMed     Abstract available
    
    
    March 2024
24. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    PubMed     Abstract available
    
    
    
25. LU Y, Clifford GM, Fairley CK, Grulich AE, et al
    Human papillomavirus and p16(INK4a) in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Int J Cancer. 2024;154:830-841.
    PubMed     Abstract available
    
    
    February 2024
26. RINALDI S, Dossus L, Keski-Rahkonen P, Kiss A, et al
    Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
    Int J Cancer. 2024 Feb 15. doi: 10.1002/ijc.34872.
    PubMed     Abstract available
    
    
    
27. SEYYEDSALEHI MS, Boffetta P
    Occupational asbestos exposure and risk of esophageal cancer: A systematic review and meta-analysis.
    Int J Cancer. 2024 Feb 10. doi: 10.1002/ijc.34881.
    PubMed     Abstract available
    
    
    
28. TAYLOR KJ, Amdal CD, Bjordal K, Astrup GL, et al
    Long-term health-related quality of life in head and neck cancer survivors: A large multinational study.
    Int J Cancer. 2024 Feb 5. doi: 10.1002/ijc.34861.
    PubMed     Abstract available
    
    
    January 2024
29. KAIMILA B, Yano Y, Mulima G, Chen Y, et al
    Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34829.
    PubMed     Abstract available
    
    
    November 2023
30. STUART CM, Meguid RA, Bronsert MR, Rodriguez Franco S, et al
    The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study.
    Int J Cancer. 2023 Nov 28. doi: 10.1002/ijc.34805.
    PubMed     Abstract available
    
    
    
31. 
    Correction to "A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers".
    Int J Cancer. 2023 Nov 19. doi: 10.1002/ijc.34789.
    PubMed    
    
    
    October 2023
32. DOCHI H, Kondo S, Komura S, Moriyama-Kita M, et al
    Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34777.
    PubMed     Abstract available
    
    
    September 2023
33. RAN X, Zeng H, Zheng R, Sun K, et al
    Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population-based study.
    Int J Cancer. 2023 Sep 20. doi: 10.1002/ijc.34730.
    PubMed     Abstract available
    
    
    
34. LEHTINEN M, Butt J, Gray P, Brenner N, et al
    HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study.
    Int J Cancer. 2023;153:1313-1315.
    PubMed    
    
    
    
35. SCOBIOALA S, Parfitt R, Matulat P, Byrne J, et al
    The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium.
    Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34732.
    PubMed     Abstract available
    
    
    
36. KUSTERS JMA, Diergaarde B, Ness A, Schim van der Loeff MF, et al
    Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex.
    Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34710.
    PubMed     Abstract available
    
    
    June 2023
37. SEO S, Keam B, Shin SH, Chae YS, et al
    A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer.
    Int J Cancer. 2023 Jun 26. doi: 10.1002/ijc.34622.
    PubMed     Abstract available
    
    
    May 2023
38. ZHENG XH, Deng CM, Zhou T, Li XZ, et al
    Saliva biopsy: Detecting the difference of EBV DNA methylation in the diagnosis of nasopharyngeal carcinoma.
    Int J Cancer. 2023 May 12. doi: 10.1002/ijc.34561.
    PubMed     Abstract available
    
    
    March 2023
39. DU Y, Feng R, Chang ET, Yin L, et al
    Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: a population-based patient cohort study in southern China.
    Int J Cancer. 2023 Mar 25. doi: 10.1002/ijc.34524.
    PubMed     Abstract available
    
    
    
40. ZHU X, Heng Y, Zhou J, Lin H, et al
    Time-varying association of Second Primary Malignancy and Long-term Survival Outcomes in Patients with Head and Neck Cancer.
    Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34520.
    PubMed     Abstract available
    
    
    
41. NGUYEN HT, Tang W, Webster ALH, Whiteaker JR, et al
    Fanconi anemia-isogenic head and neck cancer cell line pairs - a basic and translational science resource.
    Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34506.
    PubMed     Abstract available
    
    
    
42. ZHENG XH, Li XZ, Zhou T, Jiang CT, et al
    Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.
    Int J Cancer. 2023 Mar 6. doi: 10.1002/ijc.34491.
    PubMed     Abstract available
    
    
    
43. KUIJPER SC, Pape M, Vissers PAJ, Jeene PM, et al
    Trends in best-case, typical and worst-case survival scenarios of patients with non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Mar 1. doi: 10.1002/ijc.34488.
    PubMed     Abstract available
    
    
    February 2023
44. PAPE M, Kuijper SC, Vissers PAJ, Ruurda JP, et al
    Conditional relative survival in non-metastatic esophagogastric cancer between 2006 and 2020: a population-based study.
    Int J Cancer. 2023 Feb 25. doi: 10.1002/ijc.34480.
    PubMed     Abstract available
    
    
    
45. SIMBA H, Menya D, Mmbaga BT, Dzamalala C, et al
    The contribution of smoking and smokeless tobacco to esophageal squamous cell carcinoma risk in the African esophageal cancer corridor: results from the ESCCAPE multicenter case-control studies.
    Int J Cancer. 2023 Feb 2. doi: 10.1002/ijc.34458.
    PubMed     Abstract available
    
    
    January 2023
46. BUDHATHOKI S, Diergaarde B, Liu G, Olshan A, et al
    A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34444.
    PubMed     Abstract available
    
    
    
47. SUZUKI H
    HPV hijacks enhancers to activate oncogenes in head and neck squamous cell carcinoma cells.
    Int J Cancer. 2023 Jan 24. doi: 10.1002/ijc.34440.
    PubMed    
    
    
    
48. MIMA M, Okabe A, Hoshii T, Nakagawa T, et al
    Tumorigenic activation around HPV integrated sites in head and neck squamous cell carcinoma.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34439.
    PubMed     Abstract available
    
    
    
49. CARVAJAL LJ, Shing JZ, Vanegas JC, Gonzalez E, et al
    TRENDS IN INCIDENCE RATES OF HEAD AND NECK SQUAMOUS CELL CARCINOMAS OVERALL AND BY POTENTIAL RELATEDNESS TO HUMAN PAPILLOMAVIRUS, COSTA RICA 2006-2015.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34437.
    PubMed     Abstract available
    
    
    December 2022
50. BOERNER T, Carr RA, Hsu M, Michel A, et al
    Incidence and Management of Esophageal Cancer Recurrence to Regional Lymph Nodes After Curative Esophagectomy.
    Int J Cancer. 2022 Dec 27. doi: 10.1002/ijc.34417.
    PubMed     Abstract available
    
    
    October 2022
51. HERMUS M, van der Wilk BJ, Chang RTH, Collee G, et al
    Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment: the NOSANO-study.
    Int J Cancer. 2022 Oct 17. doi: 10.1002/ijc.34327.
    PubMed     Abstract available
    
    
    
52. WANG Q, Xie H, Li Y, Theodoropoulos N, et al
    Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans.
    Int J Cancer. 2022;151:1291-1303.
    PubMed     Abstract available
    
    
    
53. SOROUSH A, Malekzadeh R, Roshandel G, Khoshnia M, et al
    Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34313.
    PubMed     Abstract available
    
    
    
54. MA Y, Li W, Chen S, Lin S, et al
    Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34315.
    PubMed     Abstract available
    
    
    September 2022
55. ZHU H, Ma X, Ye T, Wang H, et al
    Esophageal cancer in China: practice and research in the new era.
    Int J Cancer. 2022 Sep 24. doi: 10.1002/ijc.34301.
    PubMed     Abstract available
    
    
    
56. POELL JB, Wils LJ, Brink A, Dietrich R, et al
    Oral cancer prediction by noninvasive genetic screening.
    Int J Cancer. 2022 Sep 7. doi: 10.1002/ijc.34277.
    PubMed     Abstract available
    
    
    August 2022
57. GHOLAP D, Dikshit R, Chaturvedi P, Chaturvedi AK, et al
    Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males.
    Int J Cancer. 2022 Aug 27. doi: 10.1002/ijc.34258.
    PubMed     Abstract available
    
    
    
58. AN L, Zheng R, Zeng H, Zhang S, et al
    The survival of esophageal cancer by subtype in China with comparison to the United States.
    Int J Cancer. 2022 Aug 1. doi: 10.1002/ijc.34232.
    PubMed     Abstract available
    
    
    July 2022
59. NOMBURG J, Bullman S, Nasrollahzadeh D, Collisson EA, et al
    An international report on bacterial communities in esophageal squamous cell carcinoma.
    Int J Cancer. 2022 Jul 15. doi: 10.1002/ijc.34212.
    PubMed     Abstract available
    
    
    June 2022
60. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    PubMed     Abstract available
    
    
    April 2022
61. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    PubMed     Abstract available
    
    
    
62. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    PubMed     Abstract available
    
    
    March 2022
63. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    PubMed     Abstract available
    
    
    
64. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    PubMed     Abstract available
    
    
    February 2022
65. ANTONSSON A, de Souza MMA, Panizza BJ, Whiteman DC, et al
    Sexual debut and association with oral HPV infection, persistence and oropharyngeal cancer - an analysis of two Australian cohorts.
    Int J Cancer. 2022 Feb 28. doi: 10.1002/ijc.33986.
    PubMed     Abstract available
    
    
    
66. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    PubMed     Abstract available
    
    
    
67. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.
    PubMed    
    
    
    
68. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    PubMed     Abstract available
    
    
    December 2021
69. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    PubMed     Abstract available
    
    
    November 2021
70. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    PubMed     Abstract available
    
    
    September 2021
71. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Otorhinolaryngology is free of charge.